Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of Pediatric Drugs for 2020.
This year has presented many challenges and I would like to take this opportunity to thank all who have contributed to ensuring the journal has thrived despite the extraordinary circumstances that the science community, and the world in general, has faced. The COVID-19 pandemic has reinforced the importance of rapid and wide dissemination of high-quality information. Springer Nature is supporting the global response to COVID-19 by making all relevant content immediately and freely available.
I would like to start by thanking the authors of the articles published in Pediatric Drugs over the course of 2020. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success. The journal is on track to publish 50 articles this year; the most popular of these so far, in terms of downloads from SpringerLink, have been:
Temrikar ZH, Suryawanshi S, Meibohm B. Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients. Pediatr Drugs. 2020;22(2):199-216.
Saraff V, Nadar R, Högler, W. New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management. Pediatr Drugs. 2020;22(2):113-121.
Olbjørn C, Rove JB, Jahnsen J. Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature. Pediatr Drugs. 2020;22(4):409-416.
Costi S, Caporali R, Cimaz R. Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy. Pediatr Drugs. 2020;22(3):263-264.
Alhersh E, Abushanab D, Al-Shaibi S, Al-Badriyeh D. Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses. Pediatr Drugs. 2020;22(4):399-408.
El-Ghandour M, Hammad B, Ghanem M, Antonios MAM. Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial. Pediatr Drugs. 2020;22(6):1–9
The quality of published articles is also testament to the diligence of the peer reviewers, whose willingness to share their expertise ensures that the journal’s content is held to the highest standard. I would like to acknowledge the following individuals who acted as reviewers for Pediatric Drugs in the last 12 months:
Rita Agarwal, USA
Mountasser M. Al-Mouqdad, Saudi Arabia
Jorge Amil Dias, Portugal
Charalampos Antachopoulos, Greece
Christian Apitz, Germany
Josephine Arendt, UK
Catherine M. Avitabile, USA
Ezgi D. Batu, Turkey
Kumar Belani, USA
Sandra Benavides, USA
Paul Bhalla, USA
David E. Bloom, USA
Christopher Brasher, Australia
Gilbert J. Burckart, USA
Jim Buttery, Australia
Waldemar A. Carlo, USA
George Chalkiadis, Australia
Eileen Chambers, USA
Catherine Chapin, USA
Herberto Chong Neto, Brazil
Imti Choonara, UK
Samuele Cortese, UK
James R. Couch Jr, USA
Giorgio Cozzi, Italy
Alexa Craig, USA
Giulia D'Arcangelo, Italy
Tom de Leeuw, the Netherlands
Lissy de Ridder, the Netherlands
Antonio De Tanti, Italy
Sieta T. de Vries, the Netherlands
Leslie A. Dervan, USA
Ami Desai, USA
Kenneth DeSantes, USA
Geneviève Durrieu, France
Daryl Efron, Australia
Karoline Ehlert, Germany
Amgad Eldib, USA
Noah Federman, USA
Giuliana Ferrante, Italy
Marco Galluzzo, Italy
Maria T. Garcia-Romero, Mexico
Teresa Giani, Italy
Jennifer L. Goldman, USA
Daniel Gonzalez, USA
Juratė Gudaitytė, Lithuania
Manuel Haschke, Switzerland
Nicholas H. G. Holford, New Zealand
Bree Holtz, USA
Gerd Horneff, Germany
Christoph P. Hornik, USA
Moninne Howlett, Ireland
Carl E. Hunt, USA
Chi Huynh, UK
Katarzyna Januszewska, Germany
Kathrin Jobski, Germany
Marybeth Jones, USA
Bridgette L. Jones, USA
Ioannis Kalampokis, USA
Konstantinos Kamperis, Denmark
David Kennaway, Australia
Ebru T. Kiliç, Turkey
Catherijne A. J. Knibbe, the Netherlands
Isabelle Kone-Paut, France
Anthony L. Kovac, USA
Paweł Kroll, Poland
Eberhard Kuwertz-Bröking, Germany
Theodore W. Laetsch, USA
Lieven Lagae, Belgium
Ana Marissa D. Lagman-Bartolome, Canada
Oren Ledder, Israel
Ming Lim, UK
Elisangela da Costa Lima, Brazil
Chien-Yu Lin, Taiwan, Republic of China
Peter A. Lio, USA
Fang Liu, UK
Mila Lovrić, Croatia
Stephen Lowis, UK
Ersilia Lucenteforte, Italy
Kris Mahadeo, USA
Anil R. Maharaj, USA
Iftekhar Mahmood, USA
Suvankar Majumdar, USA
Christoph Male, Austria
Chetan Mandelia, USA
Achille Marino, Italy
Gian Luigi Marseglia, Italy
Shirley D. Martin, USA
Andrea Mastinu, Italy
Varsha V. Mehta, USA
Erasmo Miele, Italy
Gregorio P. Milani, Italy
Ellen Mitchell, USA
Kouji Miyazaki, Japan
Maja Mockenhaupt, Germany
Masaaki Mori, Japan
Diane R. Mould, USA
Marco Mula, UK
Beate S. Müller, Germany
Simon Nadel, UK
Rinze Neuteboom, the Netherlands
Peter A. Nigrovic, USA
Hipólito Nzwalo, Portugal
Cara H. Olsen, USA
Anders A. Paerregaard, Denmark
Konstantinos Papamichael, USA
Kennerly K. S. Patrick, USA
Ian Paul, USA
Antoine Petitcollin, France
Ross E. Petty, Canada
B. Ryan Phelps, USA
Navin Pinto, USA
Dimitri Poddighe, Kazakhstan
Ganga Prasad, India
M. Sethuraman Raghuraman, India
Massimo Ralli, Italy
Michele L. Ramien, Canada
Murray M. A. Raskind, USA
Michael J. Rieder, Canada
Andrew Riordan, UK
Vilmarie Rodriguez, USA
Victoria Rollason, Switzerland
Thorsten Rosenbaum, Germany
Richard K. Russell, UK
Ayad Sabry, USA
Jumpei Saito, Japan
Cynthia F. Salorio, USA
Mark Samaan, UK
Fernando Santos, Spain
Jan N. M. Schieveld, the Netherlands
Soraya S. Seedat, South Africa
Valentina Shakhnovich, USA
Sam R. Sharar, USA
Ajoy Shetty, India
Iram Siddiqui, Canada
Namita Sood, USA
Edoardo Spina, Italy
Dan Stewart, USA
Matthew L. Stoll, USA
Anne B. Taegtmeyer, Switzerland
Burkhard Toenshoff, Germany
Chani Traube, USA
Adriana H. Tremoulet, USA
Catherine Tuleu, UK
Brian Turpin, USA
Tjitske van der Zanden, the Netherlands
Janelle D. Vaughns, USA
Alberto Verrotti, Italy
Alexander A. Vinks, USA
Terri Voepel-Lewis, USA
Jiaan D. Wang, Taiwan, Republic of China
Deepti M. Warad, USA
Margaret D. Weiss, USA
Per Wekell, Sweden
Paul V. Williams, USA
Pamela Winterberg, USA
Elaine C. Wirrell, USA
Stefan Wirth, Germany
Marco Yamazaki‐Nakashimada, Mexico
Kee Kiat Yeo, USA
Erica Zamberletti, Italy
Noam Zevit, Israel
I am also very grateful to the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
Karel Allegaert, Leuven, Belgium
Marina Aloi, Rome, Italy
John Berkenbosch, Louisville, KY, USA
Frank M. C. Besag, London, UK
Stan L. Block, Bardstown, KY, USA
Andrew Bush, London, UK
Rolando Cimaz, Florence, Italy
Saskia de Wildt, Rotterdam, the Netherlands
L. Lee Dupuis, Toronto, ON, Canada
Brian Eley, Cape Town, South Africa
Susanna Esposito, Milan, Italy
Carmen Ferrajolo, Napoli, Italy
Robert L. Findling, Baltimore, MD, USA
Dominic Fitzgerald, Westmead, Australia
Jennifer E. Girotto, Hartford, CT, USA
David A. Gremse, Mobile, AL, USA
Andreas H. Groll, Münster, Germany
Scott A. Halperin, Nova Scotia, Canada
Julian Hamilton-Shield, Bristol, UK
Gregory L. Holmes, Burlington, VT, USA
Daniel B. Horton, New Brunswick, NJ, USA
Gregory L. Kearns, Little Rock, AR, USA
Desiree Kunac, Dunedin, New Zealand
Nai Ming Lai, Kuala Lumpur, Malaysia
Stephen Lowis, Bristol, UK
Stuart M. MacLeod, Vancouver, Canada
Antje Neubert, Erlangen, Germany
Terry Nolan, Parkville, Australia
Michael E. Pichichero, Rochester, NY, USA
Emmanuel Roilides, Thessaloniki, Greece
Catherine M. Sherwin, Salt Lake City, UT, USA
Robert Sidbury, Seattle, WA, USA,
William M. Splinter, Ottawa, Canada
John van den Anker, Washington, DC, USA
Diana A. van Riet-Nales, Utrecht, the Netherlands
Karen D. Wagner, Galveston, TX, USA
Hervé Walti, Paris, France
Ian C. Wong, London, UK
C. Michel Zwaan, Rotterdam, the Netherlands
The high quality of the content published in Pediatric Drugs has been reflected in the most recent impact factor of 2.519. This places the journal high up in the second quartile of the pediatric category. Further, Pediatric Drugs has published content in a timely manner, with an average time from submission to first decision of 30 days and from acceptance to online publication of 23 days.
In 2021, Pediatric Drugs will continue to provide you with high interest, clinically relevant content in the field of pediatric pharmacotherapy. I thank you for your continued support.
With best wishes,
Rod McNab
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Pediatr Drugs 22, 571–573 (2020). https://doi.org/10.1007/s40272-020-00427-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-020-00427-x